Literature DB >> 15558304

Peri-operative filtration of disseminated cytokeratin positive cells in patients with colorectal liver metastasis.

Nils R Frühauf1, Sabine Kasimir-Bauer, Klaus Görlinger, Hauke Lang, Christian P Kaudel, Gernot M Kaiser, Karl J Oldhafer, Christoph E Broelsch.   

Abstract

BACKGROUND: Liver resection is the only potential cure for patients with colorectal liver metastasis. However, more than 30% of patients will develop tumour recurrence, probably caused by tumour cells disseminated before or during surgery. As prevention of cell dissemination is barely obtainable, alternative concepts have to be discussed.
METHODS: The potential of leukocyte adhesion filters for the removal of cytokeratin positive cells (CK+) from blood was studied in 18 patients undergoing liver resection for colorectal liver metastasis. Blood sampling was done via a liver venous catheter during hepatic mobilisation. Filtration was done with an in-line WBF2 filter system. To define the relation between surgery and cell release we compared patients' pre-operative and intra-operative blood and bone marrow (BM) samples with their CK expression using immunochemical staining.
RESULTS: CK+ cells were detected in BM samples of nine of 14 patients before surgery, indicating early dissemination. In ten of 18 patients CK+ cells were detected in blood samples during hepatic mobilisation; all ten patients underwent major liver surgery (R0 resection). In those patients recurrent disease was observed more often (P < or = 0.05). In 17 of 18 patients CK+ cells were not detectable after filtration procedure, which indicated cell adhesion to the filter medium.
CONCLUSION: Liver resection due to metastasis leads to frequent intra-operative tumour cell shedding. As the detection of CK+ cells is correlated with disease recurrence, modification of surgical techniques to prevent cell dissemination, and additional therapeutic concepts such as advanced filtration technology, have to be discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15558304     DOI: 10.1007/s00423-004-0518-3

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  25 in total

1.  Effectiveness of leukocyte filters in reducing tumor cell contamination after intraoperative blood salvage in lung cancer patients.

Authors:  P Perseghin; M Viganò; G Rocco; C Della Pona; A Buscemi; A Rizzi
Journal:  Vox Sang       Date:  1997       Impact factor: 2.144

2.  Evaluation of different methods for the detection of minimal residual disease in blood and bone marrow of patients with primary breast cancer: importance for clinical use?

Authors:  S Kasimir-Bauer; C Oberhoff; K Sliwinska; R Neumann; A E Schindler; S Seeber
Journal:  Breast Cancer Res Treat       Date:  2001-09       Impact factor: 4.872

3.  Monitoring hepatic venous hemoglobin oxygen saturation in patients undergoing liver surgery.

Authors:  M Kainuma; Y Fujiwara; N Kimura; A Shitaokoshi; K Nakashima; Y Shimada
Journal:  Anesthesiology       Date:  1991-01       Impact factor: 7.892

Review 4.  Ex-vivo resection techniques in tissue-preserving surgery for liver malignancies.

Authors:  R Raab; H J Schlitt; K J Oldhafer; A Bornscheuer; H Lang; R Pichlmayr
Journal:  Langenbecks Arch Surg       Date:  2000-04       Impact factor: 3.445

Review 5.  A summary of two clinical studies on tumor cell dissemination in primary and metastatic breast cancer: methods, prognostic significance and implication for alternative treatment protocols (Review).

Authors:  S Kasimir-Bauer; C Oberhoff; A E Schindler; S Seeber
Journal:  Int J Oncol       Date:  2002-05       Impact factor: 5.650

6.  Detection of hematogenic tumor cell dissemination in patients undergoing resection of liver metastases of colorectal cancer.

Authors:  J Weitz; M Koch; P Kienle; A Schrödel; F Willeke; A Benner; T Lehnert; C Herfarth; M von Knebel Doeberitz
Journal:  Ann Surg       Date:  2000-07       Impact factor: 12.969

7.  Anterior approach for resection of metastatic liver tumors infiltrating the caudate lobe.

Authors:  Hisashi Nakayama; Hideki Masuda; Hiroshi Miyake; Masahiko Shibata; Masahiro Fukuzawa
Journal:  Hepatogastroenterology       Date:  2002 Sep-Oct

8.  Surgical manipulation of VX2 carcinoma in the rabbit liver evokes enhancement of metastasis.

Authors:  T Nishizaki; T Matsumata; T Kanematsu; C Yasunaga; K Sugimachi
Journal:  J Surg Res       Date:  1990-07       Impact factor: 2.192

9.  The potential for reintroduction of tumor cells during intraoperative blood salvage: reduction of risk with use of the RC-400 leukocyte depletion filter.

Authors:  M J Edelman; P Potter; K G Mahaffey; R Frink; R B Leidich
Journal:  Urology       Date:  1996-02       Impact factor: 2.649

10.  Quantitation of tumorigenic disseminating and arrested cancer cells.

Authors:  E Mayhew; D Glaves
Journal:  Br J Cancer       Date:  1984-08       Impact factor: 7.640

View more
  4 in total

1.  [Anterior approach liver resection with the liver hanging maneuver. Technique and indications].

Authors:  K J Oldhafer; M Donati; M Lipp; B Keller; D Ojdanic; G A Stavrou
Journal:  Chirurg       Date:  2012-01       Impact factor: 0.955

2.  Increased detection rate and potential prognostic impact of disseminated tumor cells in patients undergoing endorectal ultrasound for rectal cancer.

Authors:  Moritz Koch; Dalibor Antolovic; Peter Kienle; Johanna Horstmann; Christian Herfarth; Magnus von Knebel Doeberitz; Jürgen Weitz
Journal:  Int J Colorectal Dis       Date:  2006-06-07       Impact factor: 2.571

Review 3.  Prognostic significance of isolated tumor cells in patients with colorectal cancer in recent 10-year studies.

Authors:  Yoshito Akagi; Tetsushi Kinugasa; Yosuke Adachi; Kazuo Shirouzu
Journal:  Mol Clin Oncol       Date:  2013-05-09

4.  Extracorporeal tumor cell filtration during extended liver surgery: first clinical use of leukocyte depletion filters--case series.

Authors:  Karl J Oldhafer; Gregor A Stavrou; Marcello Donati; Philipp Kaudel; Nils R Frühauf
Journal:  World J Surg Oncol       Date:  2013-07-17       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.